1999 to 2021 Saw Rise in Methamphetamine-Related Mortality
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 21, 2025 -- From 1999 to 2021, methamphetamine-related mortality surged dramatically, with a significant rise in heroin and synthetic opioid coinvolvement, according to a study published in the February issue of the American Journal of Preventive Medicine.
Tonazzina H. Sauda, M.B.B.S., from the University of Illinois at Urbana-Champaign, and colleagues examined sex-specific trends in methamphetamine-related mortality and the extent to which these deaths may be driven by heroin and fentanyl coinvolvement. The analysis included data from the CDC WONDER Multiple Causes of Death database (1999 to 2021).
The researchers found that over time, the methamphetamine-related mortality rate increased 58.8-fold among males (0.33 per 100,000 to 19.74 per 100,000) and 65.3-fold among females (0.12 per 100,000 to 7.96 per 100,000). The greatest increases occurred between 2019 and 2021. The proportion of deaths that coinvolved heroin and/or synthetic opioids increased from 1999 to 2021 among both sexes (males: 13.1 to 61.5 percent; females: 7.7 to 63.1 percent).
"Increasing methamphetamine-related mortality among males and females has been accompanied by a dramatic increase in the proportion of heroin and/or synthetic opioid coinvolvement among both sexes," the authors write. "Robust harm reduction efforts are needed to mitigate these increases, particularly for people who co-use stimulants and opioids."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-23 00:00
Read more
- Global Commission Presents Nuanced Approach for Defining Clinical Obesity
- Distinct Driving Patterns Seen for Seniors With Major Depressive Disorder
- FDA Approves First Generic Liraglutide Once-Daily Injection
- Fecal Microbiota Transplant Beneficial in T1DM With Bowel Symptoms
- Medicare Patients Wait Average of 34 Days to See Neurologist After Referral
- Are Young People With Eating Disorders Predisposed to Them?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions